I was yesterday at the annual meeting of the Associação Portuguesa de Nutrição Entérica e Parentérica discussing with an audience largely composed by nutritionists the routes and clinical evidence for microbiome manipulation. It is yet…
I participated in the session 1,000,000 genome initiative in 2019’s Portugal eHealth Summit. I discussed the role of AI in the clinical genomics laboratory, and the specific case of the adoption of the AI platform…
I gave a talk at the Escola Superior de Tecnologias da Saúde, a school that trains for many of the health professions, such as physiotherapists, opticians, nutritionists, pathology technicians, etc. I Discussed:
I had the opportunity to answer some questions for Health Europa about a tool we are developing to help liver cancer paints in finding the best treatment, in particular to ascertain their eligibility for curative…
I gave a talk about genomics and the development of precision medicine approaches in Asma at the ASIA meeting 2018 (Associação de Serviços e Unidades de Alergologia). I discussed the challenges of establishing a genomics-based…
I gave a talk at the 23ªS JORNADAS DE CARDIOLOGIA EM MEDICINA GERAL E FAMILIAR, in Algarve, Olhão, Hotel Real Marina, in a session on Personalised Medicine organised by. Prof. Germano de Sousa. I discussed…
I had the opportunity to discuss the trials and tribulations of moving from academia to becoming an entrepreneur with scientists attending the Career Opportunities forPostDoctoral Researchers inLife Sciences meeting in Cascais. I hope it was informative and maybe…
No Bom dia Portugal da RTP1 a explicar o que são biópsias líquidas. O vídeo pode ser visto aqui (entrevista começa no minuto 23:25)
Intrevista para a revista Pontos de Vista. Medicina de precisão: a saúde do paciente de uma forma exclusiva A medicina, tal como em outras áreas, encontra-se em constante mutação e jamais cessa a sua busca…
A new paper was just published by my Computational Genomics Group at the Instituto Gulbenkian de Ciência – CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant Progression. This was a…